Share Prices & Company Research

Stockbroking

Puretech Health Plc

Current Price 221.00p Bid 215.00p Ask 225.50p Change 0.45%
Last Updated: 09/05/2024 17:07. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

PureTech Health plc ("PureTech Health", "PureTech" or "the Company") is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.

Financial Highlights Year Ended 31/12/2023

Revenue
£3.33m
Operating Profit/Loss
£-146.20m
Dividend yield (%)
n/a
Total dividend for year
$n/a
Dividend cover
n/a
P/E Ratio
n/a
More Financials

Key Personnel

Mr Bharatt Chowrira
Executive Director
Dr. John LaMattina
Independent Non-Executive Director
Dr. Raju Kucherlapati
Independent Non-Executive Director
Ms Kiran Mazumdar Shaw
Independent Non-Executive Director
Ms Sharon Barber-Lui
Independent Non-Executive Director
Dr. Robert Langer
Non-Executive Director
Mr H. Robert Horvitz
Non-Executive Director

Stock Details

EPIC
PRTCL
ISIN
GB00BY2Z0H74
Shares in Issue
237.39m
Market cap
£524.63m

Analyst Views (2)

Strong Buy
 
100.00%
Buy
 
0%
Hold
 
0%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect the views held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
221.00p
Bid Price
215.00p
Ask Price
225.50p
Volume
8,912
Change Today
1.00p
% Change Today
0.45%
Open
218.75p
Previous Close
221.00p
Intraday High
222.00p
Intraday Low
218.50p
52 Week High
241.00p
52 Week Low
140.80p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

More Charts

Income Statement

Year End Date
31 Dec 2023
31 Dec 2022
 
$ (M)
$ (M)
Continuing Operations
Revenue
3.33
15.62
Operating Profit/Loss
-146.20
-197.81
Net Interest
5.08
138.92
Pre-Tax Profit
-36.10
-92.78
Profit After Tax from continuing operations
-66.63
-37.06
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
-66.63
-37.06
Attributable to:
Equity Holders of Parent Company
-66.63
-37.06
Minority Interests
n/a
13.29
Total Dividend Paid
$n/a
$n/a
Retained Profit/(Loss) for the Financial Year
n/a
n/a

Earnings per Share

Year End Date
31 Dec 2023
31 Dec 2022
Basic
-24.00c
-18.00c
Diluted
-24.00c
-18.00c
Adjusted
-24.00c
-18.00c
Dividend per Share
$n/a
$n/a

Assets

Year End Date
31 Dec 2023
31 Dec 2022
 
$ (M)
$ (M)
Non-Current Assets
Property, Plant & Equipment
19.36
37.24
Intangible Assets
0.91
0.83
Investment Properties
n/a
n/a
Investments
325.63
277.54
Other Financial Assets
n/a
n/a
Other Non-Current Assets
0.88
0.85
Current Assets
Inventories
n/a
n/a
Trade & Other Receivables
18.43
33.97
Cash at Bank & In Hand
191.08
149.87
Current Asset Investments
136.06
200.23
Other Current Assets
1.63
2.12
Other Assets
n/a
n/a
Total Assets
693.97
702.65

Liabilities

Year End Date
31 Dec 2023
31 Dec 2022
 
$ (M)
$ (M)
Current Liabilities
Borrowings
7.09
12.47
Other Current Liabilities
44.28
84.41
Total Current Liabilities
51.37
96.88
Non-Current Liabilities
Borrowings
18.25
34.40
Provisions
52.46
19.65
Other Non-Current Liabilities
113.66
4.13
Total Non-Current Liabilities
184.37
58.17
Other Liabilities
n/a
n/a
Total Liabilities
235.74
155.06

Net Assets

Year End Date
31 Dec 2023
31 Dec 2022
 
$ (M)
$ (M)
Net Assets
458.23
547.59

Capital & Reserves

Year End Date
31 Dec 2023
31 Dec 2022
 
$ (M)
$ (M)
Share Capital
5.46
5.46
Share Premium Account
290.26
289.62
Other Reserves
84.52
97.62
Retained Earnings
83.82
149.52
Shareholders Funds
464.07
542.22
Minority Interests/Other Equity
-5.83
5.37
Total Equity
458.23
547.59

Dividend History

Dividend Metrics

Year End Date
31 Dec 2023
31 Dec 2022
Dividend growth
n/a%
n/a%
Dividend yield
n/a%
n/a%
Dividend cover
n/a
n/a


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.